Disease Info Card

Abdominal Neoplasms

Information about Abdominal Neoplasms: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Abdominal Neoplasms

Most recent studies have shown that Abdominal Neoplasms shares some biological mechanisms with adenocarcinoma, carcinoma, kidney-neoplasm, liver-neoplasms, lung-neoplasms, lymphatic-metastasis, lymphoma, lymphoma-non-hodgkin, malignant-neoplasms, malignant-paraganglionic-neoplasm, neoplasm-metastasis, neoplasm-recurrence-local, neoplasms, neuroblastoma, ovarian-neoplasm, pain, pelvic-neoplasms, retroperitoneal-neoplasms, sarcoma, thoracic-neoplasms.

Among the many pathways, these few ones have gauged particular interests from scientists studying Abdominal Neoplasms, and have been seen in publications frequently: Angiogenesis, Cell Differentiation, Cell Growth, Cell Proliferation, Coagulation, Dehiscence, Enucleation, Excretion, Hemostasis, Immune Response, Invasive Growth, Localization, Ossification, Pathogenesis, Peristalsis, Reverse Transcription, Secretion, Segmentation, Translation

Quite a number of genes have been found to play important roles in Abdominal Neoplasms, such as AFP, ALB, CD34, CEACAM5, CEACAM7, DES, ENO2, EWSR1, GNAI1, IL2, KIT, MUC1, MYCN, PGR, PSG2, SS18L1, SST, VIM, WT1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.